F Jessen1. 1. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Deutschland, frank.jessen@ukb.uni-bonn.de.
Abstract
BACKGROUND: The number of patients with dementia is increasing. There is often uncertainty about adequate treatment. OBJECTIVES: In this paper, current treatment recommendations for dementia are summarized. MATERIAL AND METHODS: The basis of the article is the S3 guideline on dementia from the Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN) and Deutschen Gesellschaft für Neurologie (DGN). In addition, newer therapeutic approaches and recent publications have been taken into consideration. RESULTS: Before the initiation of treatment, a meaningful differential diagnosis is required to identify potentially reversible causes of dementia syndrome and to determine the correct treatment for specific dementia types. For Alzheimer's disease, acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmin) and memantine are efficacious and provide patient-related benefit. For other dementia types, there is evidence for efficacy of these drugs in some cases. Neuropsychiatric symptoms should first be managed by individual counseling and caregivers education and support. If this is not sufficiently effective, individual psychopharmacological drugs are available for specific conditions. DISCUSSION: Dementia can not be cured, but current treatment can achieve relief of disease burden and improve quality of life for patients and caregivers.
BACKGROUND: The number of patients with dementia is increasing. There is often uncertainty about adequate treatment. OBJECTIVES: In this paper, current treatment recommendations for dementia are summarized. MATERIAL AND METHODS: The basis of the article is the S3 guideline on dementia from the Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN) and Deutschen Gesellschaft für Neurologie (DGN). In addition, newer therapeutic approaches and recent publications have been taken into consideration. RESULTS: Before the initiation of treatment, a meaningful differential diagnosis is required to identify potentially reversible causes of dementia syndrome and to determine the correct treatment for specific dementia types. For Alzheimer's disease, acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmin) and memantine are efficacious and provide patient-related benefit. For other dementia types, there is evidence for efficacy of these drugs in some cases. Neuropsychiatric symptoms should first be managed by individual counseling and caregivers education and support. If this is not sufficiently effective, individual psychopharmacological drugs are available for specific conditions. DISCUSSION: Dementia can not be cured, but current treatment can achieve relief of disease burden and improve quality of life for patients and caregivers.
Authors: Daniel Weintraub; Paul B Rosenberg; Lea T Drye; Barbara K Martin; Constantine Frangakis; Jacobo E Mintzer; Anton P Porsteinsson; Lon S Schneider; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; Constantine G Lyketsos Journal: Am J Geriatr Psychiatry Date: 2010-04 Impact factor: 4.105
Authors: Robert Howard; Rupert McShane; James Lindesay; Craig Ritchie; Ashley Baldwin; Robert Barber; Alistair Burns; Tom Dening; David Findlay; Clive Holmes; Alan Hughes; Robin Jacoby; Rob Jones; Roy Jones; Ian McKeith; Ajay Macharouthu; John O'Brien; Peter Passmore; Bart Sheehan; Edmund Juszczak; Cornelius Katona; Robert Hills; Martin Knapp; Clive Ballard; Richard Brown; Sube Banerjee; Caroline Onions; Mary Griffin; Jessica Adams; Richard Gray; Tony Johnson; Peter Bentham; Patrick Phillips Journal: N Engl J Med Date: 2012-03-08 Impact factor: 91.245
Authors: Nathan Herrmann; Sandra E Black; Tiffany Chow; Jaclyn Cappell; David F Tang-Wai; Krista L Lanctôt Journal: Am J Geriatr Psychiatry Date: 2012-09 Impact factor: 4.105
Authors: Philip Scheltens; Patrick J G H Kamphuis; Frans R J Verhey; Marcel G M Olde Rikkert; Richard J Wurtman; David Wilkinson; Jos W R Twisk; Alexander Kurz Journal: Alzheimers Dement Date: 2010-01 Impact factor: 21.566
Authors: Constantine G Lyketsos; Lourdes DelCampo; Martin Steinberg; Quincy Miles; Cynthia D Steele; Cynthia Munro; Alva S Baker; Jeannie-Marie E Sheppard; Constantine Frangakis; Jason Brandt; Peter V Rabins Journal: Arch Gen Psychiatry Date: 2003-07
Authors: Pierre N Tariot; Martin R Farlow; George T Grossberg; Stephen M Graham; Scott McDonald; Ivan Gergel Journal: JAMA Date: 2004-01-21 Impact factor: 56.272